Page last updated: 2024-10-23

azathioprine and Systemic Vasculitis

azathioprine has been researched along with Systemic Vasculitis in 5 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Systemic Vasculitis: A heterogeneous group of diseases characterized by inflammation and necrosis of the blood vessel walls.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inaty, H1
Arabelovic, S1
Pagnoux, C1
Quéméneur, T1
Ninet, J1
Diot, E1
Kyndt, X1
de Wazières, B1
Reny, JL1
Puéchal, X1
le Berruyer, PY1
Lidove, O1
Vanhille, P1
Godmer, P1
Fain, O1
Blockmans, D1
Bienvenu, B1
Rollot, F1
Aït el Ghaz-Poignant, S1
Mahr, A1
Cohen, P1
Mouthon, L1
Perrodeau, E1
Ravaud, P1
Guillevin, L1
Wei, CH1
Huang, YH1
Shih, YC1
Tseng, FW1
Yang, CH1
Ciang, CO1
Leung, MH1
Lenz, P1
Dominick, J1
Barth, PJ1
Köhler, M1
Domagk, D1
Hengst, K1
Ullerich, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years Comparison of Two Strategies Combining Steroids With or Without Immunosuppressants[NCT00307671]Phase 4108 participants (Actual)Interventional2005-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for azathioprine and Systemic Vasculitis

ArticleYear
Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.
    Arthritis & rheumatology (Hoboken, N.J.), 2015, Volume: 67, Issue:4

    Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Azathioprine; Cyclophosphamide; Drug Administratio

2015

Other Studies

4 other studies available for azathioprine and Systemic Vasculitis

ArticleYear
α1-Antitrypsin deficiency in a patient diagnosed with granulomatosis with polyangiitis.
    BMJ case reports, 2013, Apr-25, Volume: 2013

    Topics: Adult; alpha 1-Antitrypsin; Azathioprine; Biopsy; Diagnosis, Differential; Female; Glucocorticoids;

2013
Sarcoidosis with cutaneous granulomatous vasculitis.
    The Australasian journal of dermatology, 2010, Volume: 51, Issue:3

    Topics: Adult; Azathioprine; Granuloma, Giant Cell; Humans; Leg Ulcer; Male; Prednisolone; Sarcoidosis; Syst

2010
Acquired factor V inhibitor in systemic vasculitis.
    International journal of rheumatic diseases, 2012, Volume: 15, Issue:2

    Topics: Aged; Autoantibodies; Azathioprine; Diagnosis, Differential; Factor V; Factor V Deficiency; Fatal Ou

2012
Severe case of intestinal vasculitis: knife's edge diagnosis and treatment.
    Endoscopy, 2012, Volume: 44 Suppl 2 UCTN

    Topics: Aged; Azathioprine; Brain Ischemia; Cyclophosphamide; Enteritis; Female; Humans; Immunosuppressive A

2012